🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
The purpose of this study was a long-term follow-up of the two studies 1103...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-04-16
Trial ID
NCT02723773
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-10
Trial ID
NCT01827839
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-03-06
Trial ID
NCT01798056
Treatments Being Tested
The purpose of this study was to evaluate the humoral immunogenicity and sa...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05219253
The purpose of this study is to assess the immunogenicity, safety, and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-17
Trial ID
NCT01777321
Treatments Being Tested
The purpose of this study is to cross-vaccinate and collect safety data in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-16
Trial ID
NCT02690207
Treatments Being Tested
The purpose of this study is to evaluate the impact of reactogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-01-16
Trial ID
NCT02979639
Treatments Being Tested
To assess the ability of RSVPreF3 OA investigational vaccine to generate an...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-28
Trial ID
NCT05966090
Treatments Being Tested
Background. A new subunit vaccine against herpes zoster (HZ) has recently b...
Status
Completed
Location
Skåne University hospital, Dept of rheumatology
Start Date
2019-03-15
Trial ID
NCT03886038
Treatments Being Tested